Effect of growth hormone treatment on children with idiopathic short stature and idiopathic growth hormone deficiency
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: There are inconsistencies in the results reported in a small number of previous studies into growth hormone (GH) treatment in Korean children with idiopathic short stature (ISS) and idiopathic growth hormone deficiency (IGHD). Thus, the authors retrospectively compared the effects of GH in ISS and IGHD. Methods: From the medical records of 26 ISS and 30 IGHD children, auxological and biochemical changes including chronologic age (CA), bone age (BA), height standard deviation score (HT-SDS), predicted adult height (PAH), midparental height (MPH), insulin-like growth factor-1 (IGF-1), and insulin-like growth factor binding protein-3 (IGFBP-3) were compared. Results: Before treatment, IGHD group had younger BA, lower BA/CA ratio, and lower IGF-1 level than those in the ISS group. During GH treatment, the levels of IGF-1 and IGFBP-3 were not different. Although annual BA increment was higher in IGHD group, and annual PAH-SDS increment was higher in ISS group, annual HT-SDS increments were not different. Both HT-SDS and PAH-SDS in the ISS group increased significantly until the end of the second year, and then those were not significantly different from MPH-SDS. In the IGHD group, the HT-SDS showed a significant increase till the end of the second year, and the PAH-SDS was not significantly changed at each year, but both HT-SDS and PAH-SDS were not significantly different from MPH-SDS at the end of the third year. Conclusion: During GH treatment, both HT-SDS and PAH-SDS approached the genetic target range of MPH-SDS after 2 years in ISS children and 3 years in IGHD children.
Abstract
Purpose: There are inconsistencies in the results reported in a small number of previous studies into growth hormone (GH) treatment in Korean children with idiopathic short stature (ISS) and idiopathic growth hormone deficiency (IGHD). Thus, the authors retrospectively compared the effects of GH in ISS and IGHD. Methods: From the medical records of 26 ISS and 30 IGHD children, auxological and biochemical changes including chronologic age (CA), bone age (BA), height standard deviation score (HT-SDS), predicted adult height (PAH), midparental height (MPH), insulin-like growth factor-1 (IGF-1), and insulin-like growth factor binding protein-3 (IGFBP-3) were compared. Results: Before treatment, IGHD group had younger BA, lower BA/CA ratio, and lower IGF-1 level than those in the ISS group. During GH treatment, the levels of IGF-1 and IGFBP-3 were not different. Although annual BA increment was higher in IGHD group, and annual PAH-SDS increment was higher in ISS group, annual HT-SDS increments were not different. Both HT-SDS and PAH-SDS in the ISS group increased significantly until the end of the second year, and then those were not significantly different from MPH-SDS. In the IGHD group, the HT-SDS showed a significant increase till the end of the second year, and the PAH-SDS was not significantly changed at each year, but both HT-SDS and PAH-SDS were not significantly different from MPH-SDS at the end of the third year. Conclusion: During GH treatment, both HT-SDS and PAH-SDS approached the genetic target range of MPH-SDS after 2 years in ISS children and 3 years in IGHD children.
참고문헌 (25)
- Korean Society of Pediatric Endocrinology, "Pediatric Endocrinology", pp.83~ (2014), Gunja Co
- Ranke MB, "Towards a consensus on the definition of idiopathic short stature", Horm Res, 45(Suppl 2), pp.64~66 (1996)
- Cohen P, "Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop", J Clin Endocrinol Metab, 93, pp.4210~4217 (2008)
- Sandro Loche, "Growth hormone treatment in non–growth hormonedeficient children", Annals of Pediatirc Endocrinology & Metabolism, 19(1), pp.1~7 (2014), 대한소아내분비학회
- Gubitosi-Klug RA, "Idiopathic short stature", Endocrinol Metab Clin North Am, 34, pp.565~580 (2005)
- Kim DH, "Response of growth hormone treatment to final height in children with growth hormone deficiency and familial short stature", J Korean Soc Pediatr Endocrinol, 4, pp.159~169 (1999)
- 강정철, "성장호르몬 결핍증과 특발성 저신장증 환아에서 성장호르몬의 치료 효과", Korean Journal of Pediatrics, 47(3), pp.310~318 (2004), 대한소아과학회
- 김슬아, "Comparison of Growth Hormone Treatment in Patients with Idiopathic Short Stature and Idiopathic Growth Hormone Deficiency", 전남의대학술지, 50(2), pp.63~66 (2014), 의과학연구소[DOI]
- Greulich WW, "Radiographic atlas of skeletal development of the hand and wrist" (1959), Stanford University Press
- Bayley N, "Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards", J Pediatr, 40, pp.423~441 (1952)
- 문진수, "2007 한국 소아 청소년 성장도표 : 개발 과정과 전망", Korean Journal of Pediatrics, 51(1), pp.1~25 (2008), 대한소아과학회
- Hyun SE, "Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents", Clin Biochem, 45, pp.16~21 (2012)
- Growth Hormone Research Society, "Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society", J Clin Endocrinol Metab, 85, pp.3990~3993 (2000)
- Savage MO, "The variability of responses to growth hormone therapy in children with short stature", Indian J Endocrinol Metab, 16(Suppl 2), pp.S178~S184 (2012)
- Lee BC, "Final height in growth hormone deficient children treated with growth hormone", J Korean Soc Pediatr Endocrinol, 8, pp.27~33 (2003)
- 최임정, "특발성과 기질성 성장호르몬 결핍증 환아에서 성장호르몬 치료 후 최종 성인신장과 신장 증가에 영향을 미치는 인자", Korean Journal of Pediatrics, 46(8), pp.803~810 (2003), 대한소아과학회
- 김호성, "Efficacy of Short-Term Growth Hormone Treatment in Prepubertal Children with Idiopathic Short Stature", Yonsei Medical Journal, 55(1), pp.53~60 (2014), 연세대학교의과대학
- Leschek EW, "Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial", J Clin Endocrinol Metab, 89, pp.3140~3148 (2004)
- Albertsson-Wikland K, "Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency", J Clin Endocrinol Metab, 93, pp.4342~4350 (2008)
- McCaughey ES, "Randomised trial of growth hormone in short normal girls", Lancet, 351, pp.940~944 (1998)
- Cohen P, "Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerations", Clin Endocrinol (Oxf), 81, pp.71~76 (2014)
- Cohen P, "Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children", J Clin Endocrinol Metab, 95, pp.2089~2098 (2010)
- Wit JM, "Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect", J Pediatr, 146, pp.45~53 (2005)
- Sotos JF, "Growth hormone significantly increases the adult height of children with idiopathic short stature: comparison of subgroups and benefit", Int J Pediatr Endocrinol, 2014, pp.15~ (2014)
- Park P, "The role of insulin-like growth factor I monitoring in growth hormone-treated children", Horm Res, 62(Suppl 1), pp.59~65 (2004)